Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study.

Iacoviello, Licia; Agnoli, C; De Curtis, A; di Castelnuovo, A; Giurdanella, Mc; Krogh, V; Mattiello, A; Matullo, G; Sacerdote, C; Tumino, R; Vineis, P; de Gaetano, G; Panico, S; Donati, M. B.